Your browser doesn't support javascript.
loading
CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process.
Altvater, Bianca; Kailayangiri, Sareetha; Spurny, Christian; Flügge, Maike; Meltzer, Jutta; Greune, Lea; Urban, Katja; Schwöppe, Christian; Brand, Caroline; Schliemann, Christoph; Hintelmann, Heike; Harrach, Saliha; Hartmann, Wolfgang; Abken, Hinrich; Kuehle, Johannes; Schambach, Axel; Görlich, Dennis; Berdel, Wolfgang E; Rossig, Claudia.
Afiliación
  • Altvater B; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Kailayangiri S; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Spurny C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Flügge M; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Meltzer J; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Greune L; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Urban K; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
  • Schwöppe C; Department of Medicine A, University of Muenster, Muenster, Germany.
  • Brand C; Department of Medicine A, University of Muenster, Muenster, Germany.
  • Schliemann C; Department of Medicine A, University of Muenster, Muenster, Germany.
  • Hintelmann H; Department of Medicine A, University of Muenster, Muenster, Germany.
  • Harrach S; Department of Medicine A, University of Muenster, Muenster, Germany.
  • Hartmann W; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster, Germany.
  • Abken H; Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT), and University of Regensburg, Regensburg, Germany.
  • Kuehle J; Center for Molecular Medicine Cologne, University of Cologne, 50931, Cologne, Germany.
  • Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
  • Görlich D; REBIRTH Research Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany.
  • Berdel WE; Division of Hematology/Oncology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
  • Rossig C; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
Cancer Gene Ther ; 30(10): 1355-1368, 2023 10.
Article en En | MEDLINE | ID: mdl-37391502
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Gene Ther Asunto de la revista: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Gene Ther Asunto de la revista: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido